Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Dai Ichi Life Insurance / Equity Bottom-Up

<ul>
 <li>
Dominant domestic player with expanding international footprint: Dai-ichi Life is the second-largest life insurer in Japan, a mature and highly penetrated market. The company is actively pursuing overseas expansion to drive growth, with a particular focus on North America and Southeast Asia. International operations are targeted to contribute approximately 40% of group profit.</li>
 <li>
Strategic shift towards capital efficiency and shareholder returns: Management has outlined a clear medium-term plan (FY2024-2026) focused on improving capital efficiency, aiming for an adjusted ROE of around 10% and reducing its cost of capital. This includes a significant reduction in domestic equity holdings and an increased dividend payout ratio to 40%.</li>
 <li>
Growth driven by overseas M&amp;A and non-insurance businesses: Facing a mature domestic market, Dai-ichi Life is actively pursuing growth through foreign acquisitions in insurance and asset management. The company has earmarked ¥300 billion for strategic investments over the next three years, with two-thirds allocated to international ventures. A recent successful tender offer for Benefit One, a corporate benefits provider, signals a move into non-insurance sectors.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Dominant domestic player with expanding international footprint: Dai-ichi Life is the second-largest life insurer in Japan, a mature and highly penetrated market. The company is actively pursuing overseas expansion to drive growth, with a particular focus on North America and Southeast Asia. International operations are targeted to contribute approximately 40% of group profit.
  
Strategic shift towards capital efficiency and shareholder returns: Management has outlined a clear medium-term plan (FY2024-2026) focused on improving capital efficiency, aiming for an adjusted ROE of around 10% and reducing its cost of capital. This includes a significant reduction in domestic equity holdings and an increased dividend payout ratio to 40%.
  
Growth driven by overseas M&amp;A and non-insurance businesses: Facing a mature domestic market, Dai-ichi Life is actively pursuing growth through foreign acquisitions in insurance and asset management. The company has earmarked ¥300 billion for strategic investments over the next three years, with two-thirds allocated to international ventures. A recent successful tender offer for Benefit One, a corporate benefits provider, signals a move into non-insurance sectors.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Dai Ichi Life Insurance (8750 JP) - Sep 2025

Japan

The Dai-ichi Life Insurance Company Ltd. underwrites and sells life, health and annuity insurance to groups and individuals. The Company offers a wide variety of insurance products to suit different needs, ranging from children's school tuition to emergency funds for the elderly.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Dai Ichi Life Insurance (8750 JP) - Sep 2025

Dominant domestic player with expanding international footprint: Dai-ichi Life is the second-largest life insurer in Japan, a mature and highly...

αSK